These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29018840)

  • 1. Sharing individual patient and parasite-level data through the WorldWide Antimalarial Resistance Network platform: A qualitative case study.
    Pisani E; Botchway S
    Wellcome Open Res; 2017; 2():63. PubMed ID: 29018840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strength in Numbers: The WWARN Case Study of Purpose-Driven Data Sharing.
    Humphreys GS; Tinto H; Barnes KI
    Am J Trop Med Hyg; 2019 Jan; 100(1):13-15. PubMed ID: 30350772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An online mapping database of molecular markers of drug resistance in Plasmodium falciparum: the ACT Partner Drug Molecular Surveyor.
    Otienoburu SD; Suay I; Garcia S; Thomas NV; Srisutham S; Björkman A; Humphreys GS
    Malar J; 2019 Jan; 18(1):12. PubMed ID: 30658642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rationale and plan for creating a World Antimalarial Resistance Network (WARN).
    Sibley CH; Barnes KI; Plowe CV
    Malar J; 2007 Sep; 6():118. PubMed ID: 17822531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
    Price RN; Dorsey G; Ashley EA; Barnes KI; Baird JK; d'Alessandro U; Guerin PJ; Laufer MK; Naidoo I; Nosten F; Olliaro P; Plowe CV; Ringwald P; Sibley CH; Stepniewska K; White NJ
    Malar J; 2007 Sep; 6():119. PubMed ID: 17822532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of a pharmacology antimalarial reference standard and proficiency testing program provided by the Worldwide Antimalarial Resistance Network (WWARN).
    Lourens C; Lindegardh N; Barnes KI; Guerin PJ; Sibley CH; White NJ; Tarning J
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3889-94. PubMed ID: 24777099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Building a Governance Strategy for CER: The Patient Outcomes Research to Advance Learning (PORTAL) Network Experience.
    Paolino AR; McGlynn EA; Lieu T; Nelson AF; Prausnitz S; Horberg MA; Arterburn DE; Gould MK; Laws RL; Steiner JF
    EGEMS (Wash DC); 2016; 4(2):1216. PubMed ID: 27141524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malaria Surveillance - United States, 2016.
    Mace KE; Arguin PM; Lucchi NW; Tan KR
    MMWR Surveill Summ; 2019 May; 68(5):1-35. PubMed ID: 31099769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncommercial US Funders' Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability.
    Whitlock EP; Dunham KM; DiGioia K; Lazowick E; Gleason TC; Atkins D
    JAMA Netw Open; 2019 Jan; 2(1):e187498. PubMed ID: 30681715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equity in global health research in the new millennium: trends in first-authorship for randomized controlled trials among low- and middle-income country researchers 1990-2013.
    Kelaher M; Ng L; Knight K; Rahadi A
    Int J Epidemiol; 2016 Dec; 45(6):2174-2183. PubMed ID: 28199646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sharing health research data - the role of funders in improving the impact.
    Terry RF; Littler K; Olliaro PL
    F1000Res; 2018; 7():1641. PubMed ID: 30647910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria Surveillance - United States, 2015.
    Mace KE; Arguin PM; Tan KR
    MMWR Surveill Summ; 2018 May; 67(7):1-28. PubMed ID: 29723168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.
    Mubyazi GM; Gonzalez-Block MA
    Malar J; 2005 Oct; 4():51. PubMed ID: 16242017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring antimalarial resistance: launching a cooperative effort.
    Sibley CH; Guerin PJ; Ringwald P
    Trends Parasitol; 2010 May; 26(5):221-4. PubMed ID: 20304706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scientific impact increases when researchers publish in open access and international collaboration: A bibliometric analysis on poverty-related disease papers.
    Breugelmans JG; Roberge G; Tippett C; Durning M; Struck DB; Makanga MM
    PLoS One; 2018; 13(9):e0203156. PubMed ID: 30231044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.